Life sciences Innovation & Investment Corridor between Lausanne & London
City-2-City trade, especially around innovation and technology, is an increasingly important avenue for Foreign and Direct Investment growth.
On 29 April in Hammersmith West London connect and interact with key innovative life sciences stakeholders and entrepreneurs from Lausanne on the shores of Lake Geneva.
Engage with a panel of Lausanne life sciences trade bodies, innovators and entrepreneurs from Innovaud, EPFL Innovation Park and Biopôle Life Sciences Park seeking to develop bi-lateral innovation and investment corridors with One Nucleus and ARC West London members.
Program:
16.30: Registration & Networking
17.00: Intro from ARC West London and One Nucleus representatives
Philippa Clark, Director of Business Development, One Nucleus
Deborah Spencer, ARC West London Health & Tech Cluster Lead
17.15: Moderated panel with representatives from Innovaud, EPFL and life sciences entrepreneurs expanding from the UK to grow in Lausanne
Moderation: Mark Stimpfig, Strategic Growth Advisor UK, Innovaud
Xavier Philipona, Senior Investment Officer, Innovaud
Michael Wilkinson, Founder & CEO, Inavya Ventures
Lennig Pedron, CEO, Swiss Trust Valley
Christopher Rudolf, Founder & CEO, Volv Global
18.00-19.00: Networking, finger food and drinks
FOR MORE INFORMATION. Contact Mark Stimpfig ([email protected]) if you are interested in meeting with these Swiss stakeholders. Please note this is an invite only event and places are limited.